The short version of synthetic peptide fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-08-08 and is reviewed periodically as new material appears.
TB-500 is a synthetic seven-amino-acid peptide with the sequence LKKTETQ, corresponding to residues 17 through 23 of the protein thymosin beta-4. The N-terminus is typically acetylated in the described form, giving a monoisotopic mass near 888.5 Da and an average mass of about 889 Da. The designation TB-500 is a catalogue label rather than a formal chemical name, and the same sequence appears in the literature under several alternative abbreviations. It is handled as a research reagent rather than a pharmaceutical product.
Thymosin beta-4 is a 43-residue actin-binding protein found in most mammalian cell types, where it participates in cytoskeletal regulation and cell migration. TB-500 represents only a short fragment of that protein and does not include the remaining residues. Whether the isolated fragment reproduces the full range of activities reported for the intact protein remains an open question. Researchers commonly treat the two as related but distinct entities when comparing results.
TB-500 is a synthetic seven-residue peptide whose sequence, LKKTETQ, matches the N-terminal actin-binding region of thymosin beta-4. It is usually supplied in an N-terminally acetylated form, a modification that blocks the free amino terminus and can influence behavior in solution. In the research literature the same sequence appears under several names, including thymosin beta-4 fragment and shortened thymosin beta-4. Because it is a short peptide rather than the full 43-residue parent protein, its measured properties differ from those reported for thymosin beta-4 as a whole, and the two are not interchangeable in experimental design.
Thymosin beta-4 itself is a small, widely expressed protein that sequesters monomeric actin and participates in cell migration, angiogenesis, and tissue repair. Researchers have examined the shortened fragment as a possible mimic of some of these activities, reasoning that the actin-binding motif lies within the first few residues. Binding to monomeric actin has been observed in cell-free systems. Whether the fragment reproduces the broader effects of the full protein in living tissue remains an open question, and findings from animal models are frequently cited without a clear bridge to human physiology.
Discussion of TB-500 appears in several distinct literatures that rarely cite one another. Peer-reviewed studies usually describe in vitro assays or small animal experiments and are cautious about extrapolation. Veterinary and sports communities circulate anecdotal reports with limited methodological detail. Commercial listings add a third layer, often using the name interchangeably with thymosin beta-4 even though the two molecules differ in size and sequence. Regulatory status varies by country, and the compound is not a licensed medicine in most jurisdictions, so readers comparing sources should check which molecule and which purity each source actually describes.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C38H68N10O14 | Acetylated heptapeptide form |
| Monoisotopic mass | 888.5 Da | Average mass about 889 Da |
| Appearance | White to off-white solid | Usually supplied as lyophilised powder |
| Solubility class | Highly water soluble | Also dissolves in aqueous buffers |
| Common synonyms | Tbeta4 fragment, thymosin beta-4 (17-23) | Refer to the same sequence |
Thymosin beta-4 was isolated from calf thymus in the early 1980s and later characterised as an abundant intracellular actin-sequestering protein. Interest in short synthetic fragments grew once the actin-binding motif had been mapped to the middle of the sequence. TB-500 came out of that line of work as a truncated analogue rather than a natural isolate, and it is now sold mainly to laboratories. Published studies on the fragment have been largely in vitro or in animal models, and controlled human trials remain sparse, so claims about effects in people rest on extrapolation.
Literature and online discussion often conflate TB-500 with full-length thymosin beta-4, even though the two differ in size and are not interchangeable in analytical terms. The fragment is produced by solid-phase peptide synthesis, and the product is a defined seven-residue chain rather than a biological extract. Because the term is a trade-style label, two vendors may supply materials of the same nominal sequence but different counter-ion content, purity, or water content. Comparisons across studies are therefore difficult unless the exact sequence and purity are reported.
The regulatory position is broadly consistent across major jurisdictions: no thymosin beta-4 fragment is an approved medicine, and laboratory material is commonly labelled as not intended for human consumption. Anti-doping rules in sport list thymosin beta-4 and its fragments among prohibited peptide hormones. Because these products travel through research-chemical channels rather than pharmaceutical supply chains, quality varies considerably between vendors. Independent testing of identity, purity and sterility is the only dependable check, and a certificate of analysis describes one batch rather than a supplier's whole catalogue.
Lyophilized peptide powder is normally held desiccated at −20 °C, with −80 °C used for longer storage periods. Allowing a sealed vial to reach room temperature before opening is standard practice, because condensation forming on cold powder introduces moisture. Once dissolved, solutions are typically kept cold and shielded from light. Repeated freeze-thaw cycles are avoided because they encourage aggregation and gradual loss of material. These conventions are general to synthetic peptides rather than unique to any one sequence.
Purity and identity are separate measurements and are often confused. Reverse-phase high-performance liquid chromatography, usually with ultraviolet detection near 214 nanometres, reports the share of total peak area belonging to the target compound. Mass spectrometry by electrospray or matrix-assisted laser desorption then checks whether the observed mass matches the expected sequence. Neither measurement alone shows that a vial holds the intended peptide. Peptide content, meaning the fraction of vial mass that is genuine peptide rather than counter-ion, water or residual acid, is reported separately and is frequently lower than the stated purity figure.
Peptide bonds are susceptible to hydrolysis under extreme pH and to enzymatic cleavage if proteases are present. Heat, oxidising agents, and prolonged exposure to light also contribute to loss of material. Aggregation can occur at high concentrations or in certain buffer systems, and it may not be visible to the eye. Storage at -20 C or below is typical for both powder and aliquoted solutions, and desiccation of the powder is preferred.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography together with mass spectrometry. The chromatogram provides a purity estimate as a percentage of total peak area, while the mass spectrum confirms that the observed mass matches the expected value. Amino acid analysis or tandem mass spectrometry sequencing can provide additional confirmation. Reported purity figures depend on the column, gradient, and detection wavelength, so values from different laboratories are not directly comparable without method details.
The compound is most often distributed as a lyophilized powder, appearing white to off-white and forming a loose cake or fluffy solid. It is hygroscopic to some degree, so brief exposure to humid air can add water weight and complicate weighing. The peptide dissolves readily in water and in neutral aqueous buffers, and aqueous solubility is generally described as high, well above the concentrations used in typical assays. Some polar organic solvents are also usable, which matters when a concentrated stock is prepared before dilution into buffer.
Storage recommendations center on keeping the dry powder cold, dry, and dark. A freezer at -20 degrees Celsius or below is conventional, and desiccant is often included to limit moisture uptake. Once dissolved, the peptide is less stable, and solutions are typically kept frozen and thawed only once. Repeated freeze-thaw cycles are a common source of losses because they promote aggregation and adsorption to container surfaces. Working aliquots are therefore prepared in advance, and glass or low-binding plastic is usually preferred over ordinary laboratory plastic.
DiCaprio turned down the role of Anakin Skywalker in Star Wars: Episode II – Attack of the Clones (2002), feeling unprepared to "take that dive" at the time. His first film that year was the biopic Catch Me If You Can, based on the life of Frank Abagnale Jr., who before his 19th birthday committed check fraud to make millions in the 1960s. Directed by Steven Spielberg, the film was shot across 147 different locations in 52 days, making it "the most adventurous, super-charged movie-making" DiCaprio had experienced yet. The film received critical acclaim and grossed $355 million against a budget of $52 million, becoming his second highest-grossing release after Titanic. Roger Ebert praised his departure from dark and troubled characters, and two Entertainment Weekly critics in 2018 called it DiCaprio's best role, labeling him "delightfully persuasive, deceptive, flirtatious, and sometimes tragic—and we dare you to find a better role, if you can". DiCaprio received his third Golden Globe nomination for his performance in the film. Also in 2002, DiCaprio starred in Martin Scorsese's Gangs of New York, a historical drama set in the mid-19th century in the Five Points district of New York City. Scorsese initially struggled selling his idea of realizing the film until DiCaprio became interested in starring in the film, and thus Miramax Films got involved with financing the project. Nonetheless, production on the film was plagued by overshooting of budgets and producer-director disagreements, resulting in an eight-month shoot.
== Modern scientific uses == Though insects were widely used throughout history for medical treatment on nearly every continent, relatively little medical entomological research has been conducted since the revolutionary advent of antibiotics. Heavy reliance on antibiotics, coupled with discomfort with insects in Western culture limited the field of insect pharmacology until the rise of antibiotic resistant infections sparked pharmaceutical research to explore new resources. Arthropods represent a rich and largely unexplored source of new medicinal compounds.
=== Terminology === The term "wet market" came into common use in Singapore in the early 1970s when the government used it to distinguish such traditional markets from the supermarkets that had become popular there. The term was added to the Oxford English Dictionary (OED) in 2016, as a term used throughout Southeast Asia. The OED's earliest cited use of the term is from The Straits Times of Singapore in 1978. The term did not originate in mainland China. No Chinese name for these markets refers to wetness: in mainland China they are officially called nongmao shichang (农贸市场, "farmers' market") or cai shichang (菜市场, "produce market") and colloquially caichang (菜场), while in Hong Kong Cantonese they are jieshi (街市, "street market"). The "wet" in "wet market" refers to the constantly wet floors due to the melting of ice used to keep food from spoiling, the washing of meat and seafood stalls and the spraying of fresh produce that is common in these markets. The term "public market" may be synonymous with "wet market", although it may sometimes refer exclusively to state-owned and community-owned markets. These markets may also be called "fresh food markets" and "good food markets" when referring to markets consisting of numerous competing vendors primarily selling fresh produce like fruits and vegetables. The term "wet market" is frequently used to signify a live animal market that sells directly to consumers, although the terms are not synonymous.
Sources: en.wikipedia.org
== Analysis == According to author Daniel Leonard Bernardi in his book, Star Trek and History: Race-ing Toward a White Future: "Like the Federation, the Comms [sic] have full command of the English language (although they speak with a homogenized 'Asian' accent). The beginning of the episode thus shows that those with white skin can be uncivilized savages and those with yellow skin can be civilized and rational [...] This would be counter to the hegemonic representation of Asians in the United States media; that diverse collective of peoples are consistently constructed in film and television as a menacing 'yellow horde.'" Bernardi goes on to say:
==== Soulja Boy ==== In June 2008, on DJ Cisco's Urban Legend mixtape, Ice-T criticized Soulja Boy (whose name is DeAndre Way) for "killing hip hop" and called his song "Crank That" "garbage" compared to the works of other hip-hop artists such as Rakim, Das EFX, Big Daddy Kane and Ice Cube. One of the comments exchanged was Ice-T telling Way to "eat a dick". The two then traded numerous videos back and forth over the Internet. These videos included a cartoon and video of Ice-T dancing on Way's behalf and an apology, but reiteration of his feelings that Way's music "sucks", on Ice-T's behalf. Musician Kanye West defended Way saying, "He came from the 'hood, made his own beats, made up a new saying, new sound and a new dance with one song".
On December 31, 2019, due to safety concerns, Brady was transferred to the USP Big Sandy, a federal prison in Kentucky. In 2021, Brady was transferred to ADX Florence, a supermax federal prison in Colorado. As of 2025, Brady remains incarcerated at Florence.
=== Symbiosis === Once the fungal hyphae make contact with root cap cells, they must continue to grow inwards to the epidermal cells and multiply to form the layers that will eventually produce the mantle. Production of the fungal mantle involves the upregulation of genes responsible for translation and cell growth, as well as those responsible for membrane synthesis and function, such as hydrophobins. Some polypeptides are only found when the fungus and plant have achieved symbiosis; these symbiosis-related (SR) proteins are termed ectomycorrhizins. Major changes in polypeptide and mRNA synthesis happen rapidly after colonization by the fungus, including the production of ectomycorrhizins. Changes include the upregulation of genes that may help new membranes to form at the symbiotic interface. The effect of the mantle on root proliferation, root hair development and dichotomous branching can be partially mimicked by fungal exudates, providing a path to identifying the molecules responsible for communication. The Hartig net initially forms from the fully differentiated inner layer of the mantle, and penetration occurs in a broad front oriented at right angles to the root axis, digesting through the apoplastic space. Some plant cells respond by producing stress- and defense-related proteins including chitinases and peroxidases that could inhibit Hartig net formation.
Sources: en.wikipedia.org
No. TB-500 is a short synthetic peptide matching residues 17 to 23 of thymosin beta-4, while the parent protein contains 43 residues. The fragment lacks the rest of the protein sequence, so the two are related but not identical.
It consists of leucine, lysine, lysine, threonine, glutamic acid, threonine, and glutamine in that order. The N-terminal leucine is usually acetylated in the forms described in catalogues.
Controlled human data is limited, and most published findings come from cell culture or animal work. This makes it difficult to state clinical effects with confidence.
No. Thymosin beta-4 is a 43-residue protein, while TB-500 refers to a seven-residue fragment corresponding to its N-terminal region. The two names are often used loosely in commercial and community writing, which obscures the difference in size, sequence, and likely behavior.